Rice University is set to welcome Pernilla Wittung-Stafshede as a professor in its Chemistry Department on July 1. Her arrival is backed by a significant $6 million grant from the Cancer Prevention and Research Institute of Texas (CPRIT). This funding is part of a broader $67 million effort aimed at enhancing cancer research in Texas, focusing on innovative methods for prevention, diagnosis, and treatment.
Wittung-Stafshede specializes in metalloproteins and protein aggregation. Her work will bolster the university’s research capabilities, paving the way for future scientific advances. Previously an associate professor at Rice from 2004 to 2008, she is enthusiastic about returning. "The collaboration opportunities with the Texas Medical Center are invaluable," she shared.
Understanding Proteins and Cancer Spread
Her research delves into the role of copper-binding proteins in cancer metastasis. These proteins, which are vital for cellular functions, can unintentionally assist cancer cells by providing copper, a metal that promotes tumor growth. Using biochemical and spectroscopic techniques, Wittung-Stafshede’s lab explores protein interactions, aiming to uncover potential therapeutic targets.
"We aim to understand how these copper proteins contribute to cancer spread," she explained. Insights from her research could not only help combat specific cancer types but might also lead to broader treatment strategies involving copper metabolism.
Connections to Neurodegenerative Diseases
Beyond cancer, Wittung-Stafshede is investigating the connection between metal-binding proteins and neurodegenerative disorders such as Alzheimer’s and Parkinson’s. Her studies focus on how these proteins can aggregate into toxic clumps called amyloids, which damage brain cells.
Key questions in her research include how metals accumulate in amyloid plaques and how this relates to neurodegeneration. "We need fundamental insights into the triggers for protein aggregation," she noted. "Understanding these processes is crucial for developing effective therapies."
Wittung-Stafshede has held various prestigious roles in academia, most recently at Chalmers University in Sweden, where she also focused on promoting gender equality in science. She has published over 270 peer-reviewed papers and served on the Nobel Committee for Chemistry since 2020.
The Impact of CPRIT
CPRIT, established in 2007 to combat cancer in Texas, has significantly influenced cancer research in the state. With an investment of $6 billion, including a voter-approved $3 billion in 2019, CPRIT has granted over $3.7 billion to research institutions and helped recruit more than 300 distinguished researchers. This support underscores the commitment to advancing cancer research and discovery, making Texas a hub for scientific innovation.
For more about CPRIT and its initiatives, you can visit CPRIT’s official site.
Source link
Cancer, Research, Cancer Prevention, Copper, Metastasis, Protein, Protein Aggregation